A detailed history of Invesco Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Invesco Ltd. holds 18,679 shares of ARCT stock, worth $342,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,679
Previous 19,952 6.38%
Holding current value
$342,386
Previous $673,000 32.54%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.35 - $44.39 $30,997 - $56,508
-1,273 Reduced 6.38%
18,679 $454,000
Q1 2024

May 14, 2024

BUY
$31.23 - $42.99 $209,116 - $287,861
6,696 Added 50.51%
19,952 $673,000
Q4 2023

Feb 12, 2024

SELL
$17.71 - $32.97 $2.13 Million - $3.97 Million
-120,315 Reduced 90.08%
13,256 $417,000
Q3 2023

Nov 13, 2023

BUY
$25.44 - $37.35 $3.13 Million - $4.59 Million
122,953 Added 1157.97%
133,571 $3.41 Million
Q2 2023

Aug 11, 2023

BUY
$23.94 - $32.36 $17,571 - $23,752
734 Added 7.43%
10,618 $304,000
Q1 2023

May 12, 2023

SELL
$14.72 - $23.97 $227,600 - $370,624
-15,462 Reduced 61.0%
9,884 $236,000
Q4 2022

Feb 13, 2023

SELL
$14.14 - $23.06 $13,970 - $22,783
-988 Reduced 3.75%
25,346 $429,000
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $2,309 - $3,917
177 Added 0.68%
26,334 $391,000
Q2 2022

Aug 15, 2022

BUY
$12.26 - $31.17 $54,152 - $137,677
4,417 Added 20.32%
26,157 $412,000
Q1 2022

May 16, 2022

BUY
$17.64 - $39.57 $237,663 - $533,126
13,473 Added 162.97%
21,740 $586,000
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $45,349 - $63,064
-1,326 Reduced 13.82%
8,267 $306,000
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $23,391 - $48,871
839 Added 9.58%
9,593 $459,000
Q2 2021

Aug 17, 2021

BUY
$25.79 - $42.11 $79,407 - $129,656
3,079 Added 54.26%
8,754 $295,000
Q1 2021

May 17, 2021

BUY
$38.75 - $86.92 $219,906 - $493,271
5,675 New
5,675 $234,000
Q4 2020

Feb 16, 2021

SELL
$34.61 - $123.66 $291,208 - $1.04 Million
-8,414 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $7.97 Million - $13.4 Million
-212,490 Reduced 96.19%
8,414 $362,000
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $2.8 Million - $12.9 Million
220,904 New
220,904 $10.3 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $487M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.